Ọrịa Alzheimer bụ ọrịa akwara na-aga n'ihu nke na-eme ka mkpụrụ ndụ ụbụrụ na-emebi emebi ma na-anwụ, na-eduga ná mbelata nke ncheta, iche echiche, na nkà iche echiche.
Ọ bụ ihe kasị akpata ọrịa dementia, na-akpata 60-80% nke ndị nile na-arịa ya.
Ọrịa ahụ na-egbu egbu n'ikpeazụ, ebe nkezi ndụ a na-atụ anya ya mgbe a chọpụtachara ya bụ afọ 4-8, ọ bụ ezie na ụfọdụ ndị nwere ike ịdị ndụ ruo afọ 20 na ọrịa ahụ.
Ọnụ ọgụgụ ndị na-anwụ n'ihi ọrịa Alzheimer na-adịgasị iche dabere n'ọmụmụ ihe na ọnụ ọgụgụ ndị a na-enyocha.
Dị ka Òtù Alzheimer si kwuo, ọrịa Alzheimer bụ ihe nke isii na-akpata ọnwụ na United States, ọ bụkwa ihe nke ise na-akpata ọnwụ n'etiti ndị dị afọ 65 na ndị tọrọ ya.
N'afọ 2019, a kọrọ na ọrịa Alzheimer bụ ihe kpatara ọnwụ nke mmadụ 121,9444 na United States.
Ọ dị mkpa iburu n'uche na ọnụọgụ ọnwụ maka ọrịa Alzheimer abụghị naanị n'ihi ọrịa ahụ n'onwe ya, kamakwa n'ihi nsogbu na nsogbu ahụike ndị ọzọ na-ebilite n'ihi ọrịa ahụ.
Ka ọrịa ahụ na-aga n'ihu, ndị mmadụ pụrụ inwe ihe isi ike n'ihe ndị ha na-eme kwa ụbọchị, dị ka iri nri, ịsa ahụ, na iyi uwe, bụ́ nke pụrụ iduga n'erighị nri nke ọma, ọrịa, na nsogbu ahụ ike ndị ọzọ.
Tụkwasị na nke ahụ, ndị na-arịa ọrịa Alzheimer pụrụ ịdị n'ihe ize ndụ dị ukwuu nke ịda, ọrịa akpa ume, na ọrịa ndị ọzọ.
Ọ bụ ezie na ọ dịghị ọgwụgwọ ọ bụla e nwere ugbu a maka ọrịa Alzheimer, e nwere ọgwụgwọ ndị pụrụ inyere aka ịchịkwa mgbaàmà ya ma mee ka ndụ dịkwuo mma.
Nnyocha na-aga n'ihu iji mepụta ọgwụgwọ ọhụrụ na n'ikpeazụ ịchọta ọgwụgwọ maka ọrịa a na-egbu egbu.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
Nkwupụta: ọgwụgwọ
A na-enye weebụsaịtị a maka ebumnuche agụmakwụkwọ na ozi naanị ma ọ bụghị inye ndụmọdụ ahụike ma ọ bụ ọrụ ọkachamara.
E kwesịghị iji ihe ọmụma e nyere mee ihe maka ịchọpụta ma ọ bụ ịgwọ nsogbu ahụ ike ma ọ bụ ọrịa, ndị na-achọ ndụmọdụ ahụike onwe ha kwesịrị ịgakwuru dọkịta nwere ikike.
Biko rịba ama na netwọkụ akwara nke na-emepụta azịza nye ajụjụ ndị ahụ, bụ ihe na-ezighi ezi mgbe ọ na-abịa na ọnụọgụ ọnụọgụ. Dịka ọmụmaatụ, ọnụọgụ ndị mmadụ chọpụtara na ọrịa akọwapụtara.
Na-achọkarị ndụmọdụ nke dọkịta gị ma ọ bụ onye na-ahụ maka ahụike ọzọ ruru eru banyere ọnọdụ ahụike. Elegharala ndụmọdụ ahụike ọkachamara anya ma ọ bụ na-egbu oge n'ịchọ ya n'ihi ihe ị gụrụ na weebụsaịtị a. Ọ bụrụ na i chere na ị nwere ike ịnweta mberede ahụike, kpọọ 911 ma ọ bụ gaa n'ọnụ ụlọ mberede kacha nso ozugbo. Enweghị mmekọrịta dọkịta na onye ọrịa na-emepụta site na weebụsaịtị a ma ọ bụ ojiji ya. Ma BioMedLib ma ndị ọrụ ya, ma onye ọ bụla na-enye aka na weebụsaịtị a, anaghị eme nkwupụta ọ bụla, kwupụta ma ọ bụ kwupụta, gbasara ozi enyere ebe a ma ọ bụ ojiji ya.
Nkwupụta: ikike nwebisiinka
Digital Millennium Copyright Act nke 1998, 17 U.S.C. § 512 (DMCA) na-enye ohere maka ndị nwe ikike nwebisiinka nke kwenyere na ihe na-apụta na ịntanetị na-emebi ikike ha n'okpuru iwu ikike nwebisiinka US.
Ọ bụrụ na ị kwenyere n'ezi okwukwe na ọdịnaya ma ọ bụ ihe ọ bụla enyere na njikọ nke weebụsaịtị anyị ma ọ bụ ọrụ na-emebi ikike nwebisiinka gị, gị (ma ọ bụ onye nnọchi anya gị) nwere ike iziga anyị ọkwa na-arịọ ka ewepụ ọdịnaya ma ọ bụ ihe, ma ọ bụ gbochie ịnweta ya.
A ghaghị izipu ọkwa n'akwụkwọ site na email (lee ngalaba "Kọntaktị" maka adreesị email) .
DMCA na-achọ ka ọkwa gị banyere mmebi iwu nwebisiinka na-ekwu na ọ gụnyere ozi ndị a: (1) nkọwa nke ọrụ nwebisiinka nke bụ isiokwu nke mmebi iwu a na-ekwu; (2) nkọwa nke ihe a na-ekwu na ọ na-emebi iwu na ozi zuru ezu iji mee ka anyị chọta ọdịnaya ahụ; (3) ozi kọntaktị maka gị, gụnyere adreesị gị, nọmba ekwentị na adreesị email; (4) nkwupụta site n'aka gị na ị nwere ezi okwukwe na ọdịnaya n'ụzọ a na-eme mkpesa na ọ bụghị ikike site n'aka onye nwe ikike, ma ọ bụ onye nnọchi anya ya, ma ọ bụ site na ọrụ iwu ọ bụla;
(5) nkwupụta site n'aka gị, nke ị bịanyere aka na ya n'okpuru ntaramahụhụ nke ịgba akaebe ụgha, na ozi dị na ọkwa ahụ ziri ezi na na ị nwere ikike iji mezuo ikike nwebisiinka nke a na-ekwu na emebi;
na (6) mbinye aka nkịtị ma ọ bụ nke elektrọnik nke onye nwe ikike ma ọ bụ onye e nyere ikike ime ihe n'aha onye nwe ikike.
Ọ bụrụ na i tinyeghị ozi niile dị n'elu, ọ nwere ike ime ka a na-egbu oge n'ịhazi mkpesa gị.
Mkparịta ụka
Biko zitere anyị email na ajụjụ ọ bụla / aro.
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
